Jubilant Pharmova

Jubilant Pharmova

JUBLPHARMA

 ₹ 889.38
- ₹ 52.61
5.58%
Healthcare
 ₹ 0.00
(%)1D
Updated: 25 Apr 2025, 03:31:34 pm IST
Stock Score
Open Price
 ₹ 942.41
Prev. Close
 ₹ 941.99
 ₹ 880.17
Day Low
 ₹ 942.51
Day High

 ₹ 685.90
52 Week Low
 ₹ 1,303.95
52 Week High

Quick Bite

Price To Earnings Ratio

-232.21

Sector PE

65.09

PB Ratio

2.62

Sector PB

8.49

EPS

-3.83

Dividend Yield

1.79

Today's Volume

435.261 K

5 Day Avg. Volume

321.035 K

PEG Ratio

2.02

Market Cap.

₹ 14,560.00 Cr.

About Jubilant Pharmova

Jubilant Pharmova Limited is an India-based integrated pharmaceutical company. The Company's segments include Radiopharma, Allergy Immunotherapy, Contract Development and Manufacturing Organisation-Sterile Injectables, Generics, Contract Research, Development and Manufacturing Organisation, Proprietary Novel Drugs, and Management Services. The Radiopharma segment comprises radiopharmaceuticals including radio pharmacies. The Contract Development and Manufacturing Organisation-Sterile Injectables segment includes contract development and manufacturing organisation-sterile injectables products. The Generics segment includes solid dosage formulations. The Contract Research, Development and Manufacturing Organisation segment includes drug discovery services, and active pharmaceutical ingredients. The Proprietary Novel Drugs segment includes patient-focused biopharmaceutical business working to address unmet medical needs in oncology and autoimmune diseases.

Jubilant Pharmova Share Price

Jubilant Pharmova Limited is an India-primarily based totally incorporated pharmaceutical company. The Company's segments encompass Pharmaceuticals, Contract Research and Development Services and Proprietary Novel Drugs. The Pharmaceuticals phase, via absolutely owned subsidiary Jubilant Pharma Limited, is engaged in manufacture and deliver of energetic pharmaceutical ingredients (APIs), strong dosage formulations, radiopharmaceuticals, hypersensitive reaction remedy merchandise and agreement production of sterile injectables and non-sterile merchandise via six production centers in India, United States and Canada and a community of about forty eight radio pharmacies withinside the United States. The Contract Research and Development Services phase affords drug discovery and improvement offerings in addition to medical records software program and carrier solutions. The Proprietary Novel Drugs phase is a patient-targeted biopharmaceutical enterprise operating to cope with unmet scientific wishes in oncology and autoimmune diseases.

Jubilant Pharmova FAQs

How to Buy Jubilant Pharmova Share?

up
To purchase Jubilant Pharmova shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Jubilant Pharmova (ticker symbol: JUBLPHARMA) on the trading platform provided by your broker and purchase the shares.

What's Jubilant Pharmova share price today?

up
The stock price of Jubilant Pharmova as of 01 May 2025 is ₹889.38

What is the Market Cap of Jubilant Pharmova?

up
Market capitalisation represents the total market value of a company's outstanding shares. As of 01 May 2025, Jubilant Pharmova (ticker symbol: JUBLPHARMA) has a market capitalisation of approximately ₹1,45,60,00,00,000.00

What is the PE and PB ratio of Jubilant Pharmova?

up
Jubilant Pharmova Ltd's price-to-book ratio as of 01 May 2025 is 2.62, reflecting the market's valuation compared to its asset value. As of 01 May 2025, the trailing twelve months P/E (price-to-earnings) ratio is -232.21, indicating the market values the company at around - ₹232.21 for every ₹1 of earnings

What is the 52 Week High and Low of Jubilant Pharmova Share?

up
Jubilant Pharmova Ltd (JUBLPHARMA) hit its 52-week high at ₹1,303.95, and its 52-week low at ₹685.90.
Begin your investment journey today
Login/Register
Start Now